Endocrine Pharmaceuticals Overview

  • Founded
  • 1995
Founded
  • Status
  • Private
  • Employees
  • 6
Employees
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 4

Endocrine Pharmaceuticals General Information

Description

Provider of therapeutic research services intended to specialize in the hormonal regulation of tissue mass and integrity. The company's services help in the treatment of benign and malignant tissue overgrowth conditions affecting the pituitary, prostate, breast, heart and kidneys, enabling healthcare providers to cure their patients of tumour growth and improve their lives.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • Wilderness End, Tadley Common Road
  • Tadley
  • Hampshire RG26 3TA
  • England, United Kingdom
+44 07866 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Endocrine Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 31-Dec-2019 Completed Product In Beta Test
2. Grant Completed Product In Beta Test
1. Early Stage VC Completed Product In Beta Test
To view Endocrine Pharmaceuticals’s complete valuation and funding history, request access »

Endocrine Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
John Hart Ph.D Founder, Chief Executive Officer & Board Member
To view Endocrine Pharmaceuticals’s complete executive team members history, request access »

Endocrine Pharmaceuticals Board Members (4)

Name Representing Role Since
John Hart Ph.D Endocrine Pharmaceuticals Founder, Chief Executive Officer & Board Member 000 0000
Lyell Fairlie Endocrine Pharmaceuticals Board Member 000 0000
You’re viewing 2 of 4 board members. Get the full list »

Endocrine Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Endocrine Pharmaceuticals Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angels 5K Angel Group Minority 000 0000 000000 0
Cambridge Research and Innovation Venture Capital Minority 000 0000 000000 0
East Midlands Business Angels Angel Group Minority 000 0000 000000 0
Government of UK Government 000 0000 000000 0
To view Endocrine Pharmaceuticals’s complete investors history, request access »